These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21344482)

  • 1. A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro.
    Mikelis C; Lamprou M; Koutsioumpa M; Koutsioubas AG; Spyranti Z; Zompra AA; Spiliopoulos N; Vradis AA; Katsoris P; Spyroulias GA; Cordopatis P; Courty J; Papadimitriou E
    J Cell Biochem; 2011 Jun; 112(6):1532-43. PubMed ID: 21344482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta.
    Mikelis C; Sfaelou E; Koutsioumpa M; Kieffer N; Papadimitriou E
    FASEB J; 2009 May; 23(5):1459-69. PubMed ID: 19141530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotrophin-induced endothelial cell migration is regulated by xanthine oxidase-mediated generation of reactive oxygen species.
    Tsirmoula S; Lamprou M; Hatziapostolou M; Kieffer N; Papadimitriou E
    Microvasc Res; 2015 Mar; 98():74-81. PubMed ID: 25582077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin.
    Pariser H; Ezquerra L; Herradon G; Perez-Pinera P; Deuel TF
    Biochem Biophys Res Commun; 2005 Jul; 332(3):664-9. PubMed ID: 15925565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
    Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
    J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotrophin stimulates tyrosine phosphorylation of beta-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase beta/zeta.
    Pariser H; Perez-Pinera P; Ezquerra L; Herradon G; Deuel TF
    Biochem Biophys Res Commun; 2005 Sep; 335(1):232-9. PubMed ID: 16105548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration.
    Lampropoulou E; Logoviti I; Koutsioumpa M; Hatziapostolou M; Polytarchou C; Skandalis SS; Hellman U; Fousteris M; Nikolaropoulos S; Choleva E; Lamprou M; Skoura A; Megalooikonomou V; Papadimitriou E
    Sci Rep; 2018 Apr; 8(1):5893. PubMed ID: 29651006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprotinin stimulates angiogenesis and human endothelial cell migration through the growth factor pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta.
    Koutsioumpa M; Hatziapostolou M; Mikelis C; Koolwijk P; Papadimitriou E
    Eur J Pharmacol; 2009 Jan; 602(2-3):245-9. PubMed ID: 19059395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor.
    Koutsioumpa M; Poimenidi E; Pantazaka E; Theodoropoulou C; Skoura A; Megalooikonomou V; Kieffer N; Courty J; Mizumoto S; Sugahara K; Papadimitriou E
    Mol Cancer; 2015 Feb; 14(1):19. PubMed ID: 25644401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor A (VEGF-A) decreases expression and secretion of pleiotrophin in a VEGF receptor-independent manner.
    Poimenidi E; Theodoropoulou C; Koutsioumpa M; Skondra L; Droggiti E; van den Broek M; Koolwijk P; Papadimitriou E
    Vascul Pharmacol; 2016 May; 80():11-9. PubMed ID: 26924457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo.
    Ulbricht U; Eckerich C; Fillbrandt R; Westphal M; Lamszus K
    J Neurochem; 2006 Sep; 98(5):1497-506. PubMed ID: 16923162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the interaction of pleiotrophin and VEGFA
    Choleva E; Menounou L; Ntenekou D; Kastana P; Tzoupis Η; Katraki-Pavlou S; Drakopoulou M; Spyropoulos D; Andrikopoulou A; Kanellopoulou V; Enake MK; Beis D; Papadimitriou E
    Eur J Pharmacol; 2024 Aug; 977():176692. PubMed ID: 38821164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
    Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesis.
    Ball M; Carmody M; Wynne F; Dockery P; Aigner A; Cameron I; Higgins J; Smith SD; Aplin JD; Moore T
    Placenta; 2009 Jul; 30(7):649-53. PubMed ID: 19481257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta as regulators of angiogenesis and cancer.
    Papadimitriou E; Pantazaka E; Castana P; Tsalios T; Polyzos A; Beis D
    Biochim Biophys Acta; 2016 Dec; 1866(2):252-265. PubMed ID: 27693125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotrophin selectively binds to vascular endothelial growth factor receptor 2 and inhibits or stimulates cell migration depending on α
    Lamprou M; Kastana P; Kofina F; Tzoupis Η; Barmpoutsi S; Sajib MS; Koutsioumpa M; Poimenidi E; Zompra AA; Tassopoulos D; Choleva E; Tselios T; Mikelis CM; Papadimitriou E
    Angiogenesis; 2020 Nov; 23(4):621-636. PubMed ID: 32681389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.
    Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF
    Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.
    Deuel TF
    Biochim Biophys Acta; 2013 Oct; 1834(10):2219-23. PubMed ID: 23777859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta/zeta.
    Polytarchou C; Hatziapostolou M; Poimenidi E; Mikelis C; Papadopoulou A; Parthymou A; Papadimitriou E
    Int J Cancer; 2009 Apr; 124(8):1785-93. PubMed ID: 19058221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mechanical loading on the expression of pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta in a rat spinal deformity model.
    Kaspiris A; Chronopoulos E; Grivas TB; Vasiliadis E; Khaldi L; Lamprou M; Lelovas PP; Papaioannou N; Dontas IA; Papadimitriou E
    Cytokine; 2016 Feb; 78():7-15. PubMed ID: 26615567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.